← Back
$LCTX All transactions

Lineage Cell Therapeutics, Inc.

M

$ Value

$0

Shares

6,075

Price

$0

Filed

Feb 13

Insider

Name

Samuel George A. III

Title

General Counsel and Secretary

CIK

0001878732

Roles

Officer

Transaction Details

Transaction Date

2026-02-11

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis. | Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options. | Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 6,075 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction | The Reporting Person was granted 24,303 RSUs on February 11, 2022, that vested with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026.

Filing Info

Accession No.

0001193125-26-052020

Form Type

4

Issuer CIK

0000876343

Samuel George A. III's History

Date Ticker Type Value
2026-03-05 LCTX A $0
2026-02-11 LCTX M
2026-02-11 LCTX F $5K
2026-02-11 LCTX M $0
2025-12-19 LCTX A
2025-12-19 LCTX F $109

Other Insiders at LCTX (90d)

Insider Bought Sold Last
Culley Brian M
President and CEO
2026-03-05
Samuel George A. III
General Counsel and Secretary
2026-03-05
Howe Jill Ann
Chief Financial Officer
2026-03-05